← Back to Search

Radiation Therapy

MR-Guided Radiation Therapy for Cancer (MRgRT Trial)

N/A
Recruiting
Led By Michael Milosevic, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new type of cancer treatment that uses magnetic resonance to guide the radiation. They want to see if it works well and if it affects the workflow of the people administering the treatment.

Who is the study for?
This trial is for adults over 18 who can give informed consent and are scheduled to receive imaging or treatment at the Princess Margaret Cancer Centre's MRgRT facility. There are no specific exclusion criteria mentioned.
What is being tested?
The study focuses on assessing how well magnetic resonance-guided radiation therapy (MRgRT) works in a research setting and its effects on the clinical team's workflow at the cancer center.
What are the potential side effects?
Since this trial is evaluating technical performance rather than a drug, it doesn't list specific side effects like medication trials do. However, general risks may include those typically associated with radiation therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Measure tumor size before, during and after radiotherapy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Magnetic resonance - guided radiation therapy (MRgRT)Experimental Treatment1 Intervention
Magnetic resonance (MR) - guided radiation therapy

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,524 Previous Clinical Trials
503,054 Total Patients Enrolled
Michael Milosevic, MDPrincipal InvestigatorUniversity Health Network, Toronto
10 Previous Clinical Trials
998 Total Patients Enrolled

Media Library

Magnetic resonance-guided radiation therapy (MRgRT) (Radiation Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT02701712 — N/A
Solid Tumors Research Study Groups: Magnetic resonance - guided radiation therapy (MRgRT)
Solid Tumors Clinical Trial 2023: Magnetic resonance-guided radiation therapy (MRgRT) Highlights & Side Effects. Trial Name: NCT02701712 — N/A
Magnetic resonance-guided radiation therapy (MRgRT) (Radiation Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02701712 — N/A
~3 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top